PRV-015 in Gluten-free Diet Non-responsive Celiac Disease
Public ClinicalTrials.gov record NCT04424927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of PRV-015 in Adult Patients With Non-Responsive Celiac Disease as an Adjunct to a Gluten-free Diet
Study identification
- NCT ID
- NCT04424927
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Provention Bio, a Sanofi Company
- Industry
- Enrollment
- 388 participants
Conditions and interventions
Conditions
Interventions
- PRV-015 Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 23, 2020
- Primary completion
- Jul 29, 2024
- Completion
- Jul 29, 2024
- Last update posted
- Oct 19, 2025
2020 – 2024
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Los Angeles | California | 90036 | — |
| Clinical Site | Ventura | California | 93003 | — |
| Clinical Site | Denver | Colorado | 80209 | — |
| Clinical Site | Leesburg | Florida | 34748 | — |
| Clinical Site | Tampa | Florida | 33613 | — |
| Clinical Site | Winter Park | Florida | 32789 | — |
| Clinical Site | Chicago | Illinois | 60637 | — |
| Clinical Trial Site | Northbrook | Illinois | 60062 | — |
| Clinical Trial Site | Chevy Chase | Maryland | 20815 | — |
| Clinical Site | Boston | Massachusetts | 02111 | — |
| Clinical Site | Chesterfield | Michigan | 48047 | — |
| Clinical Site | Rochester | Minnesota | 55905 | — |
| Clinical Site | Morristown | New Jersey | 07960 | — |
| Clinical Trial Site | Brooklyn | New York | 11235 | — |
| Clinical Site | New Windsor | New York | 12553 | — |
| Clinical Trial Site | New York | New York | 10032 | — |
| Clinical Site | Raleigh | North Carolina | 27607 | — |
| Clinical Trial Site | Dublin | Ohio | 43016 | — |
| Clinical Site | Philadelphia | Pennsylvania | 19104 | — |
| Clinical Site | Uniontown | Pennsylvania | 14401 | — |
| Clinical Site | Warwick | Rhode Island | 02886 | — |
| Clinical Trial Site | North Charleston | South Carolina | 29405 | — |
| Clinical Site | Nashville | Tennessee | 37212 | — |
| Clinical Trial Site | Cedar Park | Texas | 78613 | — |
| Clinical Site | Garland | Texas | 75044 | — |
| Clinical Site | West Jordan | Utah | 84088 | — |
| Clinical Site | Bellevue | Washington | 98004 | — |
| Clinical Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04424927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04424927 live on ClinicalTrials.gov.